References
- 1. Organization WH. Coronavirus (COVID-19). 2020. 2020.
- 2. Mishra E, Goyal AK, Rath G. Recent advances in drug delivery systems in antiviral therapy. 2018.
- 3. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269-71.
- 4. Oldfield V, Plosker GL. Lopinavir/ritonavir. Drugs. 2006;66(9):1275-99.
- 5. Llibre JM. Development of darunavir over the entire spectrum of HIV infection. Enfermedades Infecciosas y Microbiologia Clinica. 2018;36:3-9.
- 6. Khalili JS, Zhu H, Mak NSA, Yan Y, Zhu Y. Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID‐19. Journal of medical virology. 2020.
- 7. Cao Y-c, Deng Q-x, Dai S-x. Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence. Travel Medicine and Infectious Disease. 2020:101647.
- 8. Deng L, Li C, Zeng Q, Liu X, Li X, Zhang H, et al. Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study. Journal of Infection. 2020.
Details
Primary Language
Turkish
Subjects
Clinical Sciences
Journal Section
Editorial
Authors
Ali Ciftciler
This is me
0000-0001-7612-2707
Türkiye
Publication Date
July 3, 2021
Submission Date
December 7, 2020
Acceptance Date
December 21, 2020
Published in Issue
Year 2021 Volume: 2 Number: 1